“Classified research constitutes a much smaller portion of the U.S. biodefense program than many might suspect,” according to Gerald L. Epstein, a specialist at the Center for Strategic and International Studies.
“Nevertheless, classified DHS biodefense research will constitute one of the most controversial parts of the U.S. biodefense program,” he observed in Congressional testimony (pdf) earlier this month.
“Even more so than in other areas of science, the biological sciences have enjoyed a tradition of openness and international collaboration–and this heavy presumption of openness should continue. Since disease continues to kill millions of people around the world each year, any restrictions on relevant scientific knowledge could have serious consequences,” he told a House Science Subcommittee.
“Yet the existence of hostile, witting adversaries that are determined to wreak devastation and that are known to be interested in biological weapons mandates that this openness not be absolute.”
In March 8 testimony (at pp. 6-8), Dr. Epstein presented his views on how to reconcile these conflicting imperatives.
To increase the real and perceived benefit of research funding, funding agencies should develop challenge goals for their extramural research programs focused on the impact portion of their mission.
Without trusted mechanisms to ensure privacy while enabling secure data access, essential R&D stalls, educational innovation stalls, and U.S. global competitiveness suffers.
Satellite imagery has long served as a tool for observing on-the-ground activity worldwide, and offers especially valuable insights into the operation, development, and physical features related to nuclear technology.
This year’s Red Sky Summit was an opportunity to further consider what the role of fire tech can and should be – and how public policy can support its development, scaling, and application.